[Topical neomycin: risks and benefits. Plea for withdrawal].
Assier-Bonnet
H
H
Service de Dermatologie, Hôpital Henri Mondor, Créteil.
Revuz
J
J
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects; D003429:Cross Reactions; D017449:Dermatitis, Allergic Contact / Q000453:epidemiology / Q000209:etiology; D004342:Drug Hypersensitivity / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects; D012871:Skin Diseases / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D009355:Neomycin